CN104069426A - Traditional Chinese medicine for treating scleroderma - Google Patents

Traditional Chinese medicine for treating scleroderma Download PDF

Info

Publication number
CN104069426A
CN104069426A CN201410199863.6A CN201410199863A CN104069426A CN 104069426 A CN104069426 A CN 104069426A CN 201410199863 A CN201410199863 A CN 201410199863A CN 104069426 A CN104069426 A CN 104069426A
Authority
CN
China
Prior art keywords
radix
chinese medicine
traditional chinese
skin
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410199863.6A
Other languages
Chinese (zh)
Inventor
杜仁波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410199863.6A priority Critical patent/CN104069426A/en
Publication of CN104069426A publication Critical patent/CN104069426A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine for treating scleroderma. The traditional Chinese medicine for treating scleroderma comprises the following components in percentage by weight: 10-14% of polygonum multiflorum, 7-11% of pangolin, 13-17% of pseudo ginseng, 4-8% of schisandra chinensis, 13-17% of salvia miltiorrhiza, 10-14% of safflower, 7-11% of codonopsis pilosula, 10-14% of herba epimedii, 7-11% of Aconitum anthora, 1-5% of curcuma zedoary, 13-17% of leonurus, 4-8% of sergeant gloryvine, 4-8% of astragalus membranaceus and 1-5% of angelica sinensis. The traditional Chinese medicine has the functions of tonifying qi, nourishing blood, activating blood and removing blood stasis, regulating the immunologic function of the human body and improving microcirculation of the skin, and has the advantages that the curative effect is good, the medicine has no toxic or side effect and is safe and convenient for treating skin numbness.

Description

A kind ofly treat sclerodermatous Chinese medicine
technical field:
The present invention relates generally to the field of Chinese medicines, relates in particular to a kind of sclerodermatous Chinese medicine for the treatment of.
background technology:
Scleroderma, in human body, deficiency of both QI and blood, space between skin and muscles dredge to slit, and healthy energy can not be escorted, and the mixed intrusion of taking advantage of a weak point in opponent's defence of wind, cold, wet three gas, makes collaterals of human stop up resistance, and, then there is arthromyodynia in coagulation of QI-blood.The generation of primary disease is mainly because plain body deficient qi and blood, interspaces of skin and muscles being loose, the damp that is affected by the cold are fallen ill.Modern medicine thinks that primary disease is to add repeatedly lasting acute and chronic infection and a kind of immunologic mechanism dysfunctional disease of causing by inherited genetic factors.Chinese medicine is thought the pathogens such as all wind and cold is damp and hot invasion and attack skin, and the resistance of skin channels is closed, and part or whole skin swelling, sclerderm, variable color, appear in coagulation of QI-blood, and the BI-syndrome related to skin of insensitive, the apathetic person's meaning of affected part is demonstrate,proved.
summary of the invention:
The object of the invention is exactly in order to make up the defect of prior art, and a kind of sclerodermatous Chinese medicine for the treatment of is provided, and it has determined curative effect, the advantage having no side effect.
The present invention is achieved by the following technical solutions:
Treat a sclerodermatous Chinese medicine, it is characterized in that: the weight proportion of its each raw material components is: Radix Polygoni Multiflori 10-14, Squama Manis 7-11, Radix Notoginseng 13-17, Fructus Schisandrae Chinensis 4-8, Radix Salviae Miltiorrhizae 13-17, Flos Carthami 10-14, Radix Codonopsis 7-11, Herba Epimedii 10-14, Radix aconiti szechenyiani 7-11, Rhizoma Curcumae 1-5, Herba Leonuri 13-17, Caulis Sargentodoxae 4-8, Radix Astragali 4-8, Radix Angelicae Sinensis 1-5.
Treat a sclerodermatous Chinese medicine, it is characterized in that: the weight proportion of its each raw material components is: Radix Polygoni Multiflori 12, Squama Manis 9, Radix Notoginseng 15, Fructus Schisandrae Chinensis 6, Radix Salviae Miltiorrhizae 15, Flos Carthami 12, Radix Codonopsis 9, Herba Epimedii 12, Radix aconiti szechenyiani 9, Rhizoma Curcumae 3, Herba Leonuri 15, Caulis Sargentodoxae 6, the Radix Astragali 6, Radix Angelicae Sinensis 3.
Advantage of the present invention is:
Chinese medicine of the present invention is reused the Chinese medicines such as benefiting QI and nourishing blood, blood circulation promoting and blood stasis dispelling, and mediator's body immunity function, improves skin microcirculation, reach for treatment BI-syndrome related to skin patient there is good effect, have no side effect, safe ready.
the specific embodiment:
Treat a sclerodermatous Chinese medicine, the weight of its each raw material components (g) is: Radix Polygoni Multiflori 12, Squama Manis 9, Radix Notoginseng 15, Fructus Schisandrae Chinensis 6, Radix Salviae Miltiorrhizae 15, Flos Carthami 12, Radix Codonopsis 9, Herba Epimedii 12, Radix aconiti szechenyiani 9, Rhizoma Curcumae 3, Herba Leonuri 15, Caulis Sargentodoxae 6, the Radix Astragali 6, Radix Angelicae Sinensis 3.
Take above raw material components, according to the routine fashion of decoction, add water and boil decoction and take, every day potion, potion is taken at twice.
For proof, the present invention has good curative effect, enumerates model case as follows:
Case one:
Wang, female, 43 years old, main suit: suffer from scleroderma, point stiffly, poker-faced, skin is hard, and body is changed one's position unfavorable, also with symptoms such as joint aches, anorexia flatulence, menoxenias.Give treatment by Chinese herbs of the present invention after one month, the symptoms such as joint aches, anorexia flatulence, menoxenia are obviously alleviated; After two first quarter moons, symptom all disappears.Follow up a case by regular visits to without recurrence.
Case two:
Field, female, 39 years old.Main suit: suffer from scleroderma, finger and foot's stiff skin, movable difficulty, also poor with sensation of oppression over the chest with shortness of breath, appetite, the spiritual symptom such as not good.Give treatment by Chinese herbs of the present invention after one month, sensation of oppression over the chest with shortness of breath, appetite are poor, the not good transference cure that waits of spirit, and finger and foot can slightly bend and stretch; After three months, symptom all disappears, and follows up a case by regular visits to not recurrence in a year.
Case three:
Ten thousand certain, man, 40 years old.Main suit: suffer from scleroderma, face, hand, foot and skin of neck be stiff, finger can not bend and stretch, poker-faced, also with symptoms such as joint aches, appetite are poor.Give after treatment by Chinese herbs two weeks of the present invention, appetite takes a turn for the better to some extent, and after January, joint aches symptom is obviously alleviated; After three first quarter moons, patient's recovery from illness, follows up a case by regular visits to not recurrence in a year.

Claims (2)

1. the sclerodermatous Chinese medicine for the treatment of, is characterized in that: the weight proportion of its each raw material components is: Radix Polygoni Multiflori 10-14, Squama Manis 7-11, Radix Notoginseng 13-17, Fructus Schisandrae Chinensis 4-8, Radix Salviae Miltiorrhizae 13-17, Flos Carthami 10-14, Radix Codonopsis 7-11, Herba Epimedii 10-14, Radix aconiti szechenyiani 7-11, Rhizoma Curcumae 1-5, Herba Leonuri 13-17, Caulis Sargentodoxae 4-8, Radix Astragali 4-8, Radix Angelicae Sinensis 1-5.
2. a kind of sclerodermatous Chinese medicine for the treatment of according to claim 1, is characterized in that: the weight proportion of its each raw material components is: Radix Polygoni Multiflori 12, Squama Manis 9, Radix Notoginseng 15, Fructus Schisandrae Chinensis 6, Radix Salviae Miltiorrhizae 15, Flos Carthami 12, Radix Codonopsis 9, Herba Epimedii 12, Radix aconiti szechenyiani 9, Rhizoma Curcumae 3, Herba Leonuri 15, Caulis Sargentodoxae 6, the Radix Astragali 6, Radix Angelicae Sinensis 3.
CN201410199863.6A 2014-05-13 2014-05-13 Traditional Chinese medicine for treating scleroderma Pending CN104069426A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410199863.6A CN104069426A (en) 2014-05-13 2014-05-13 Traditional Chinese medicine for treating scleroderma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410199863.6A CN104069426A (en) 2014-05-13 2014-05-13 Traditional Chinese medicine for treating scleroderma

Publications (1)

Publication Number Publication Date
CN104069426A true CN104069426A (en) 2014-10-01

Family

ID=51591292

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410199863.6A Pending CN104069426A (en) 2014-05-13 2014-05-13 Traditional Chinese medicine for treating scleroderma

Country Status (1)

Country Link
CN (1) CN104069426A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104524375A (en) * 2015-01-09 2015-04-22 杨茹芹 Traditional Chinese medicine composition treating lung-defense pain obstruction type scleroderma
CN104784634A (en) * 2015-03-31 2015-07-22 刘凤伟 Traditional Chinese medicine preparation for treating diffuse systemic scleroderma

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104524375A (en) * 2015-01-09 2015-04-22 杨茹芹 Traditional Chinese medicine composition treating lung-defense pain obstruction type scleroderma
CN104784634A (en) * 2015-03-31 2015-07-22 刘凤伟 Traditional Chinese medicine preparation for treating diffuse systemic scleroderma
CN104784634B (en) * 2015-03-31 2018-12-14 刘凤伟 A kind of Chinese materia medica preparation for treating diffusivity systemic scleroderma

Similar Documents

Publication Publication Date Title
CN103316222B (en) Traditional Chinese medicine composition for treating pleurisy and preparation method thereof
CN103341133A (en) Traditional Chinese medicine composition for treating fatty liver and preparation method thereof
CN104069426A (en) Traditional Chinese medicine for treating scleroderma
CN103127294A (en) Traditional Chinese medicine composition for treating chronic nephritis
CN103385964A (en) Method for treating acute pelvic inflammatory disease by using traditional Chinese medicine
CN104707089A (en) Coronary heart disease treating traditional Chinese medicine formula
CN103372083A (en) Chinese medicinal composition for treating spontaneous perspiration
CN104274815A (en) Traditional Chinese medicine composition for treating dysmenorrhea due to deficiency of vital energy and blood
CN104056222A (en) Menstruation-regulating beauty tonic pill
CN103816414A (en) Traditional Chinese medicinal composition for treating human spontaneous perspiration
CN103417861A (en) Traditional Chinese medicine composition for treating chronic cardiac insufficiency
CN102772727A (en) Tablet for nourishing blood and preventing abortion
CN102397403A (en) Medicine for treating kidney dysfunction
CN104069275A (en) Traditional Chinese medicament for treating skin numbness
CN105169045A (en) Traditional Chinese medicine decoction for treating pulmonary consumption with cough
CN105935381A (en) Traditional Chinese medicine for improving insomnia
CN104056021A (en) Traditional Chinese medicine for treating leucoderma
CN103735642A (en) Traditional Chinese medicine for preventing influenza
CN103656271A (en) Traditional Chinese medicine composition for treating chronic cholecystitis
CN104547101A (en) Traditional Chinese medicine composition for treating rheumatic heart disease
CN103800850A (en) Traditional Chinese medicine formula for treating goiter
CN104042747A (en) Traditional Chinese medicine composition for treating rectocele
CN102370841A (en) Chinese herbal prescription for treating stagnation of qi due to depression of liver in later menstrual period
CN111110789A (en) Traditional Chinese medicine composition prescription for treating phlegm-dampness collateral-blocking type cervical spondylosis
CN104547841A (en) Traditional Chinese medicine composition for treating numbness of limbs

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20141001

RJ01 Rejection of invention patent application after publication